rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

500660 GLAXO Group (A)

GlaxoSmithKline Pharmaceuticals Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
17 Feb,15:48
2685.70   19.65   0.74%
Volume 3,827
Prev close 2,666.05
Day's H/L (Rs.) 2,692.00 - 2,671.00
52wk H/L (Rs.) 3,850.00 - 2,600.00
Mkt Cap (Rs. Cr) 22,747.88
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
17 Feb,15:59
2692.20   22.40   0.84%
Volume 4,317
Prev close 2669.80
Day's H/L (Rs.) 2,700.00 - 2,676.55
52wk H/L (Rs.) 3,872.00 - 2,600.00
Turnover (Rs. Lacs) 116.07
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for GlaxoSmithKline Pharmaceuticals Ltd.  (See all 1,091 market voices)   

140 Characters
  Cancel
Pooja - 14 hour(s) ago Call_us_for _Stock_Market_Training_learning_or_Market_profit or. whatsappp 7400574001 or....for.live.trading.call...VISIT....www.goo.gl/TkglBg ..........
#GlaxoSmithKline-Pharmaceuticals-Ltd
Reply   |   Share
Pooja - 14 hour(s) ago CALL.us.4.BEST.stock.advise.or. whatsappp 7400574001 or....for.live.trading.call...VISIT....www.goo.gl/TkglBg ..........
#GlaxoSmithKline-Pharmaceuticals-Ltd
Reply   |   Share

Realtime news for GlaxoSmithKline Pharmaceuticals Ltd. (See all 108 news)

20 February 2017, 02:40
GlaxoSmithKline Pharma Q3 profit dips 33% at Rs 53 cr - 11 Feb 2017
Uterine Fibroid Treatment Market (2016-2022): By Type, Treatment & Region with F. Hoffmann-La Roche, Boston Scientific, Richard Wolf Medical Instruments, Eli Lilly and Company & GSK Dominating - 06 Feb 2017
Fortune 500 Co. in Costa Rica Sets New Trend With Pet Day - 06 Feb 2017
Increasing access to medicines via collaboration and digitisation - 06 Jan 2017
GSK Pharma Chief Exits After Losing CEO Spot - 20 Jan 2017

BSE Announcements from GlaxoSmithKline Pharmaceuticals Ltd. (See all)

Results Press Release for December 31, 2016 - 11 Feb 2017
Change in Directorate - 11 Feb 2017

Company details for GlaxoSmithKline Pharmaceuticals Ltd.

Report Card

PE Ratios
60.72
EPS (Rs.)
44.23
Sales (Rs. Cr)
706.38
Face Value (Rs.)
10
Net Profit
Margin (%)
 
13.60
Last Bonus
1:1
Last Dividend(%)
500
Return on
Average Equity
 
21.85

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

GlaxoSmithKline Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in GlaxoSmithKline Pharmaceuticals Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare GlaxoSmithKline Pharmaceuticals Ltd. with other stocks

Torrent Pharmaceuticals Ltd.
1,315.20
Wockhardt Ltd.
686.05
Show more companies
Torrent Pharmaceuticals Ltd.
1,315.20
Wockhardt Ltd.
686.05
Ipca Laboratories Ltd.
531.25
Lupin Ltd.
1,490.65
Marksans Pharma Ltd.
39.10
Natco Pharma Ltd.
721.55
Pfizer Ltd.
1,777.60
Piramal Enterprises Ltd.
1,691.65
Strides Shasun Ltd.
1,194.30
Sun Pharma Advanced Research Company Ltd.
314.65
Show less companies
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
 
 
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close